-

MEDISCA Announces Exclusive Partnership with ANANDA HEALTH for Global Distribution of Full Spectrum CBD

PLATTSBURGH, N.Y.--(BUSINESS WIRE)--MEDISCA, a global leader in the pharmaceutical compounding industry, is proud to announce a partnership with Ananda Health, the leading CBD provider to US independent pharmacies. MEDISCA will be the exclusive pharmaceutical compounding distributor of Ananda Professional products in the United States, Canada and Australia.

“MEDISCA has been closely monitoring the CBD segment over the past several years and we have seen awareness and demand increase for compounding pharmacists across many geographies. To ensure that we can provide our pharmacists the best-in-class CBD product range we are very pleased to announce our exclusive distribution partnership with Ananda Health,” said Panagiota Danopoulos, SVP Global Strategy and Innovation at MEDISCA.

David Neu, CEO of Ananda Health states, “We could not be more proud to partner with the global leader in the pharmaceutical compounding industry. MEDISCA has over 30 years of experience in the industry and both of our organizations have core values that are deeply aligned around education, quality and customer care.” Neu continued “This partnership is one of the most important milestones in the professionalization of the CBD industry. This is the first time a multinational distributor will be carrying ingestible hemp-derived CBD products.”

“CBD is an exciting new category that still requires significant research and education to ensure it can help as many patients as possible. In conjunction with Ananda Health, we are very excited to be able to give our pharmacists access to the research, tools and training to improve patient outcomes," said Ms. Danopoulos.

MEDISCA will have the complete line of Ananda Professional products available beginning February 1, 2021.

About MEDISCA

MEDISCA is the leader in providing turnkey solutions to the pharmaceutical compounding industry and allied health care professionals worldwide. Through its global partners, LP3 Network and MEDISCA Network, MEDISCA is committed to being a complete resource for prescribers, pharmacists and pharmacy technicians engaged in personalized medicine by offering educational trainings, products, and support. Founded in 1989, the company has locations in Canada, the United States and Australia, optimizing its service to the international market. For more information about MEDISCA, please visit www.medisca.com and follow us on Twitter at @medisca.

About Ananda Health

In the United States, the Ananda Health is the #1 provider of hemp-derived CBD for retail pharmacies. The Company produces nutraceutical products for human and pet consumption, as well as topical creams and salves. See www.anandahemp.com and www.anandaprofessional.com. The Company also supplies its leading Ananda Hemp CBD products to Australians via the SAS B program.

The Company owns or controls key parts of the value chain in each business, from breeding, growing and production to sales and marketing. Our value proposition to customers is built on strong brands and quality products.

Contacts

Ekaterina Dobrokhotova
Director of Global Marketing
661 Route 3, Unit C
Plattsburgh, NY 12901
Medisca.com
1-800-932-1039

MEDISCA


Release Versions

Contacts

Ekaterina Dobrokhotova
Director of Global Marketing
661 Route 3, Unit C
Plattsburgh, NY 12901
Medisca.com
1-800-932-1039

More News From MEDISCA

Medisca Launches Global Peptide Division

MONTREAL--(BUSINESS WIRE)--Medisca today announced the launch of Medisca Peptides, a dedicated global division focused on expanding access to API-grade peptides and building an integrated peptide platform for pharmaceutical and personalized medicine markets worldwide. As the peptide landscape evolves, Medisca is proactively building the capabilities and infrastructure needed to support API-grade peptides within applicable regulatory frameworks. The launch represents a significant long-term comm...

Medisca Enters Its Next Chapter Under Founder Antonio Dos Santos

MONTREAL--(BUSINESS WIRE)--For more than 35 years, Dos Santos has helped shape Medisca into a global leader in pharmaceutical compounding. As Chief Executive Officer, he will lead the company's long-term strategy, with a focus on expanding Medisca's global reach, investing in new areas of growth, strengthening strategic partnerships, and continuing to advance the products, services, education, and expertise that healthcare professionals rely on every day. "When I founded Medisca, my vision was...

Medisca and dsm–firmenich Partner to Expand Access to Pharmaceutical-Grade Vitamin APIs for U.S. Compounding Market

MONTREAL--(BUSINESS WIRE)--Medisca, a global leader in personalized pharmaceutical medicine, has entered into a strategic partnership with dsm–firmenich, a leading ingredient manufacturer serving regulated pharmaceutical markets worldwide. Through this partnership, Medisca will make a portfolio of pharmaceutical-grade vitamin active pharmaceutical ingredients (APIs) available to U.S. compounding professionals, expanding access to ingredients manufactured within European cGMP environments and su...
Back to Newsroom